Stay updated on Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.6.4 has been added to the study's history, replacing the previous revision v3.6.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, replacing the previous v3.6.2. This indicates a minor update to the page's presentation/metadata rather than changes to the study content.SummaryDifference0.1%

- Check43 days agoChange DetectedNew version entry v3.6.2 was added to the study's record history, while the previous v3.6.0 entry was removed. This reflects an update to the page's versioning rather than changes to the study data or content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study history adds quick-access links for eligibility and contact information, and updates the latest revision label to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.6%

- Check65 days agoChange DetectedA new revision entry v3.5.5 was added to the record history and the previous revision v3.5.4 was removed, updating the study's version history.SummaryDifference0.1%

- Check86 days agoChange DetectedThe Study Record Versions now include a new revision entry v3.5.4, replacing the previous v3.5.3 in the history.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin Combo in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Relapsed MM Clinical Trial page.